Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
50
WHD Quote, Financials, Valuation and Earnings
Last price:
$44.52
Seasonality move
:
7.74%
Day range:
$43.92 - $46.33
52-week range:
$33.80 - $70.01
Dividend yield:
1.18%
P/E ratio:
15.69x
P/S ratio:
2.87x
P/B ratio:
2.72x
Volume:
924.5K
Avg. volume:
690.8K
1-year change:
-8.45%
Market cap:
$3B
Revenue:
$1.1B
EPS (TTM):
$2.81
Analysts' Opinion
-
Consensus RatingCactus has received a consensus rating of Hold. The company's average rating is a Hold based on 2 Buy ratings, 3 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $50.88, Cactus has an estimated upside of 14.51% from its current price of $44.10.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $39.00 representing 11.57% downside risk from its current price of $44.10.
Fair Value
-
According to the consensus of 5 analysts, Cactus has 14.51% upside to fair value with a price target of $50.88 per share.
WHD vs. S&P 500
-
Over the past 5 trading days, Cactus has overperformed the S&P 500 by 3.83% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Cactus does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Cactus has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Cactus reported revenues of $280.3M.
Earnings Growth
-
Cactus has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Cactus reported earnings per share of $0.64.
Enterprise value:
2.9B
EV / Invested capital:
2.20x
Price / LTM sales:
2.87x
EV / EBIT:
9.75x
EV / Revenue:
2.53x
PEG ratio (5yr expected):
1.36x
EV / Free cash flow:
12.48x
Price / Operating cash flow:
14.18x
Enterprise value / EBITDA:
8.07x
Gross Profit (TTM):
$438.9M
Return On Assets:
11.36%
Net Income Margin (TTM):
16.78%
Return On Equity:
15.79%
Return On Invested Capital:
15.79%
Operating Margin:
24.48%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $770.9M | $1.1B | $1.1B | $274.1M | $280.3M | |
| Gross Profit | $277M | $432M | $438.9M | $105.3M | $107.7M | |
| Operating Income | $193.4M | $305.4M | $298.7M | $75.9M | $68.6M | |
| EBITDA | $234.7M | $360.5M | $355.4M | $90.9M | $84.3M | |
| Diluted EPS | $2.08 | $2.52 | $2.81 | $0.59 | $0.64 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $439.4M | $546.4M | $527.5M | $617M | $809M | |
| Total Assets | $877.9M | $1B | $1.5B | $1.6B | $1.8B | |
| Current Liabilities | $55.1M | $102.5M | $186.6M | $190.7M | $167M | |
| Total Liabilities | $318.8M | $411.1M | $594.4M | $475.3M | $463.7M | |
| Total Equity | $559.1M | $615.1M | $925.8M | $1.1B | $1.3B | |
| Total Debt | -- | -- | $151.7M | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $161.1M | $366.1M | $271.4M | $86.3M | $41.5M | |
| Cash From Investing | -$651.4M | -$28.4M | -$44M | -$6.8M | -$15.5M | |
| Cash From Financing | $270M | -$220M | -$71.8M | -$20.1M | -$21.8M | |
| Free Cash Flow | $124.6M | $330.1M | $229.9M | $78.4M | $31.3M | |
WHD
Sector
Market Cap
$3B
$60.1M
Price % of 52-Week High
62.99%
63.64%
Dividend Yield
1.18%
0%
Shareholder Yield
1.32%
4.64%
1-Year Price Total Return
-8.45%
-27.51%
Beta (5-Year)
1.488
0.652
Dividend yield:
1.18%
Annualized payout:
$0.50
Payout ratio:
18.23%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$41.89
200-day SMA
Sell
Level
$55.05
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Buy
Level
$42.23
Relative Strength Index (RSI14)
Buy
Level
61.36
ADX Line
Neutral
Level
0
Williams %R
Sell
Level
-7.7103
50-day SMA
Buy
Level
$41.08
MACD (12, 26)
Buy
Level
0.28
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Neutral
Level
--
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (7.0996)
Buy
CA Score
(Annual)
Level (1.0705)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.1026)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (8)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. The company has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.
Stock Forecast FAQ
In the current month, WHD has received 2 Buy ratings 3 Hold ratings, and 0 Sell ratings. The WHD average analyst price target in the past 3 months is $50.88.
-
Where Will Cactus Stock Be In 1 Year?
According to analysts, the consensus estimate is that Cactus share price will rise to $50.88 per share over the next 12 months.
-
What Do Analysts Say About Cactus?
Analysts are divided on their view about Cactus share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Cactus is a Sell and believe this share price will drop from its current level to $39.00.
-
What Is Cactus's Price Target?
The price target for Cactus over the next 1-year time period is forecast to be $50.88 according to 5 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 3 analysts rate the stock a Hold.
-
Is WHD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Cactus is a Hold. 3 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of WHD?
You can purchase shares of Cactus via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Cactus shares.
-
What Is The Cactus Share Price Today?
Cactus was last trading at $44.52 per share. This represents the most recent stock quote for Cactus. Yesterday, Cactus closed at $44.10 per share.
-
How To Buy Cactus Stock Online?
In order to purchase Cactus stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
43
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
55
CTRN alert for Jun 4
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
